Global Cognitive Dysfunction Devices Market Size
Market for cognitive dysfunction devices was valued at US$ 6.3 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.5% to reach US$ 10.3 billion by 2034.
A cognitive disorder, a neurocognitive ailment, is defined as any condition that significantly impairs a person's cognitive function. Deficits in cognitive capacity that are acquired rather than developed are known as cognitive disorders. They often get worse with time and may be linked to underlying brain malfunction. Mental skills like memory, reasoning, and thinking are affected by several medical disorders, including frontotemporal degeneration, prion disease, Parkinson's disease, Lewy body disease, traumatic brain injury (TBI), dementia/neurocognitive issues associated with HIV infection, and Parkinson's disease. Examples of neurocognitive disorders (formerly known as dementia) include delirium, attention deficit disorder, schizophrenia, and mild and major disorders. According to the cognitive mental illness viewpoint, psychological disorders result from interference with our primary cognitive dysfunction devices market functions, such as memory.